336
Participants
Start Date
January 31, 2007
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
estradiol, 10 mcg
Tablets, administered intravaginally twice weekly
Novo Nordisk Investigational Site, Glostrup Municipality
Novo Nordisk Investigational Site, Herlev
Novo Nordisk Investigational Site, Virum
Novo Nordisk Investigational Site, Drammen
Novo Nordisk Investigational Site, Hillerød
Novo Nordisk Investigational Site, Roskilde
Novo Nordisk Investigational Site, Århus N
Novo Nordisk Investigational Site, Turku
Novo Nordisk Investigational Site, Nîmes
Novo Nordisk Investigational Site, Tampere
Novo Nordisk Investigational Site, Nantes
Novo Nordisk Investigational Site, Kuopio
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Oulu
Novo Nordisk Investigational Site, Évry
Novo Nordisk Investigational Site, Brno
Novo Nordisk Investigational Site, Brno
Novo Nordisk Investigational Site, Olomouc
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Espoo
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Pécs
Novo Nordisk Investigational Site, Szeged
Novo Nordisk Investigational Site, Hamar
Novo Nordisk Investigational Site, Larvik
Novo Nordisk Investigational Site, Oslo
Novo Nordisk Investigational Site, Sandvika
Novo Nordisk Investigational Site, Ski
Novo Nordisk Investigational Site, Stavanger
Novo Nordisk Investigational Site, Stavanger
Novo Nordisk Investigational Site, Trondheim
Novo Nordisk Investigational Site, Gothenburg
Novo Nordisk Investigational Site, Gothenburg
Novo Nordisk Investigational Site, Linköping
Novo Nordisk Investigational Site, Malmo
Novo Nordisk Investigational Site, Norrköping
Novo Nordisk Investigational Site, Uppsala
Lead Sponsor
Novo Nordisk A/S
INDUSTRY